Apria Healthcare Durable Medical Equipment & Medical Supplies Location: 98-720 Kuahao Pl, Pearl City, Hawaii 96782 Phone: (808) 485-0178 |
Longs Drugs #09275 Durable Medical Equipment & Medical Supplies Location: 850 Kamehameha Hwy, Pearl City, Hawaii 96782 Phone: (808) 455-4555 |
North Shore Prosthetics And Orthoti Prosthetic/Orthotic Supplier Location: 98-425 Kamehameha Highway, Pearl City, Hawaii 96782 Phone: (808) 744-5642 |
Longs Drugs #04728 Durable Medical Equipment & Medical Supplies Location: 1130 Kuala St, Pearl City, Hawaii 96782 Phone: (808) 456-5302 |
Walmart Pharmacy 10-5274 Durable Medical Equipment & Medical Supplies Location: 1131 Kuala St, Pearl City, Hawaii 96782 Phone: (808) 485-8792 |
Sam's Pharmacy 10-6410 Durable Medical Equipment & Medical Supplies Location: 1000 Kamehameha Hwy, Pearl City, Hawaii 96782 Phone: (808) 454-0182 |
Times Supermarket - Times Pharmacy Pharmacy Location: 98-1264 Kaahumanu St, Pearl City, Hawaii 96782 Phone: (808) 483-3078 |
National Seating & Mobility Inc Durable Medical Equipment & Medical Supplies Location: 96-1173 Waihona St, Pearl City, Hawaii 96782 Phone: (808) 842-3889 |
Legacy Medical Supply Llc Durable Medical Equipment & Medical Supplies Location: 98-138 Hila Place, Pearl City, Hawaii 96782 Phone: (808) 312-1632 |
News Archive
Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).
Scientists have found a marker that can indicate your likelihood of suffering from rheumatoid arthritis (RA) even sixteen years before the condition takes effect. A team from the Kennedy Institute of Rheumatology at Oxford University found that a blood test that looks for antibodies that recognize the protein tenascin-C could reliably show those who will contract the condition.
JDRF announced today another important step on the road to the development of an artificial pancreas - an automated system to better manage the blood sugar of people with type 1 diabetes - with the establishment of a research program to speed the development of faster-acting insulin.
An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.
University of Georgia research has found that inorganic mercury, which was previously thought to be a less harmful form of the toxic metal, is very damaging to key cell processes.
› Verified 2 days ago